CROs Consider a Post-COVID Clinical Trial Landscape

CROs (Contract Research Organizations) are hopeful that the COVID-19 pandemic will not last forever. Jim Reilly, Vice President of Vault R&D at Veeva discusses ongoing challenges. He notes that siloed systems are one major issue reported by CROs in a new Annual CRO Report and that companies looking to the future now will be in a better position once the pandemic ends.

He remarks, “COVID-19 accelerated the industry’s move towards digital strategies and solutions to keep existing trials on track and start new studies faster. The CROs that already used modern applications were in a much better position to manage the transition to remote work and respond to the pressures of COVID-19, such as enabling digital access to information for study monitors.” Read more here.

(Source: Jenni Spinner, Outsourcing-Pharma, 3/29/21)